Bath & Body Works, Inc. $BBWI Stock Position Lifted by GMT Capital Corp

Key Points

• GMT Capital Corp has increased its stake in Bath & Body Works, Inc. by 7.3%, now owning approximately 1.75% of the company, valued at $113,327,000.
• The company reported quarterly earnings of $0.37 EPS, meeting expectations, while revenue was $1.55 billion, marking a slight decrease of 0.8% from the previous year.
• Bath & Body Works will pay a quarterly dividend of $0.20 on September 5th, with an annualized dividend yield of 2.7%.

GMT Capital Corp raised its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 7.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,737,700 shares of the company's stock after purchasing an additional 255,600 shares during the quarter. Bath & Body Works accounts for about 6.0% of GMT Capital Corp's portfolio, making the stock its 4th biggest position. GMT Capital Corp owned approximately 1.75% of Bath & Body Works worth $113,327,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. SVB Wealth LLC purchased a new stake in shares of Bath & Body Works during the first quarter valued at approximately $35,000. Golden State Wealth Management LLC increased its position in shares of Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after acquiring an additional 642 shares during the last quarter. UMB Bank n.a. increased its position in shares of Bath & Body Works by 65.9% during the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after acquiring an additional 596 shares during the last quarter. Ancora Advisors LLC purchased a new stake in shares of Bath & Body Works during the fourth quarter valued at approximately $67,000. Finally, GKV Capital Management Co. Inc. purchased a new stake in shares of Bath & Body Works during the first quarter valued at approximately $69,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Price Performance

NYSE BBWI traded up $1.59 during trading hours on Thursday, reaching $32.15. 2,779,704 shares of the stock traded hands, compared to its average volume of 5,207,755. The stock has a 50 day simple moving average of $30.69 and a two-hundred day simple moving average of $30.68. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87. The company has a market cap of $6.63 billion, a price-to-earnings ratio of 9.52, a price-to-earnings-growth ratio of 0.98 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter last year, the business posted $0.37 earnings per share. The company's revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be given a dividend of $0.20 per share. The ex-dividend date is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.5%. Bath & Body Works's dividend payout ratio (DPR) is presently 23.74%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on BBWI shares. Barclays increased their price objective on Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a report on Friday, August 29th. JPMorgan Chase & Co. increased their price objective on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a report on Monday, July 28th. Citigroup reduced their price objective on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a report on Tuesday, August 19th. UBS Group reduced their price objective on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a report on Friday, August 29th. Finally, Telsey Advisory Group reissued an "outperform" rating and set a $38.00 price objective on shares of Bath & Body Works in a report on Thursday, August 28th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Bath & Body Works currently has an average rating of "Moderate Buy" and a consensus price target of $41.62.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.